Companies: 10,795·Total market cap: $144.5T
Aditxt, Inc.

Aditxt, Inc.

ADTXNASDAQHealthcare● Active
$0.05
$-0.01(-19.65%)
Market Cap$1672
P/E Ratio
52W High$53453.52
52W Low$0.0463
Overview

Aditxt, Inc. (ADTX) PE Ratio — Current & Historical Data

Trailing twelve months (TTM) P/E, forward P/E, PEG, and annual PE history — from market prices and filings.

adtx · pe ratio · data through Dec 31, 2025

Core PE Ratio Metrics

Trailing 12 months · TTM

The price-to-earnings (P/E) ratio for Aditxt, Inc. (ADTX) measures how much investors pay for each dollar of the company's trailing earnings. ADTX's current PE ratio of N/A is calculated by dividing its stock price of $0.05 by its TTM earnings per share of -$2575.18.

N/A
P/E Ratio (TTM)N/A — Company is not profitable (TTM)

Source: FMP · /ratios-ttm · /analyst-estimates · 2025-12-31

Forward P/E
N/A
FY2026 est. EPS $-22828802400.00
Based on 1 analyst
EPS (TTM)
-$2575.18
TTM · diluted EPS
PEG Ratio
0.00
Below 1.0 · Growth adjusted
Source: FMP · /ratios-ttm · /ratios annual · /analyst-estimates · /stock-peers · Aditxt, Inc. SEC 10-K & 10-Q filings · US GAAPUpdated: 2026-06-08

PE Ratio History

2017 – 2025 · Annual
PE Ratio (TTM)
EPS (Annual)

▸ FMP /ratios?period=annual&limit=20 · priceToEarningsRatio + netIncomePerShare (Annual)

PE Ratio vs Peers

Biotechnology · 6 peers · Annual PE
CompanyMarket CapPE (Annual)vs AvgEPS (TTM)
Aditxt, Inc.
Aditxt, Inc.You
ADTX
$0MN/A-$2575.18
Ainos, Inc.
Ainos, Inc.
AIMD
$9MN/A-$3.46
Adlai Nortye Ltd.
Adlai Nortye Ltd.
ANL
$543MN/A-$3.33
Apollomics, Inc.
Apollomics, Inc.
APLM
$15MN/A-$7.57
Athira Pharma, Inc.
Athira Pharma, Inc.
ATHA
$27MN/A-$24.70
BioLineRx Ltd.
BioLineRx Ltd.
BLRX
$14MN/A-$0.29
Citius Pharmaceuticals, Inc.
Citius Pharmaceuticals, Inc.
CTXR
$7MN/A-$3.38

* N/A — Company is not profitable (TTM) · excluded from industry average · ▸ FMP /stock-peers + /ratios?limit=1 · priceToEarningsRatio

Annual PE Ratio History

Showing 9 of 9 years
Fiscal Year EndPE RatioEPS (TTM)YoY ChangePE vs Max
2025-12-31Latest
FY2025
$-1116.70
2024-12-31
FY2024
$-3062.41
2023-12-31
FY2023
$0.00
2022-12-31
FY2022
$0.00
2021-12-31
FY2021
$0.00
2020-12-31
FY2020
$0.00
2019-12-31
FY2019
$0.00
2018-12-31
FY2018
$0.00
2017-12-31
FY2017
$0.00

▸ FMP /ratios?period=annual&limit=20 · priceToEarningsRatio + netIncomePerShare · Zero extra API

About PE Ratio & Methodology

The price-to-earnings (P/E) ratio for Aditxt, Inc. (ADTX) measures how much investors pay for each dollar of the company's trailing earnings. ADTX's current PE ratio of N/A is calculated by dividing its stock price of $0.05 by its TTM earnings per share of -$2575.18.

PE Ratio = Stock Price ÷ EPS (TTM)
= $0.05 ÷ -$2575.18 = N/A
TTMTrailing Twelve Months — sum of the most recent 4 quarterly EPS figures
Forward PEStock price ÷ analyst consensus EPS estimate for the next fiscal year
PEGPE ÷ earnings growth rate — values below 1.0 suggest growth may justify the premium
Figures tie to SEC 10-K/10-Q and FMP ratio endpoints where noted.

Frequently asked questions

ADTX pe ratio · 6 questions

ADTX's current PE ratio is N/A as of 2026-06-08, based on a stock price of $0.05 and TTM EPS of -$2575.18. Data sourced from Financial Modeling Prep via ADTX's SEC 10-K and 10-Q filings.

ADTX PE ratioWhat is ADTX PE ratioCurrent PE ratio of ADTXADTX PE ratio today

Source: FMP · /ratios-ttm · /ratios annual · /analyst-estimates · /stock-peers · Aditxt, Inc. SEC 10-K & 10-Q filings · US GAAP · Updated: 2026-06-08